These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 26139577)

  • 1. Transplant immuno-diagnostics: crossmatch and antigen detection.
    South AM; Grimm PC
    Pediatr Nephrol; 2016 Jun; 31(6):897-905. PubMed ID: 26139577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A; Holgersson J; Alheim M
    Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
    Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
    Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of crossmatch testing when Luminex-SAB is negative in renal transplantation.
    Jayant K; Reccia I; Julie BM; Sharma A; Halawa A
    Pol Przegl Chir; 2018 Feb; 90(1):41-46. PubMed ID: 29513250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Luminex and negative flow cytometry in kidney transplantation: a systematic review and meta-analysis.
    Buttigieg J; Ali H; Sharma A; Halawa A
    Nephrol Dial Transplant; 2019 Nov; 34(11):1950-1960. PubMed ID: 30508114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminex-based virtual crossmatching for renal transplantation in South Africa.
    Worsley CM; Mayne ES; Suchard MS
    S Afr Med J; 2011 Dec; 102(1):40-3. PubMed ID: 22273137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
    Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
    Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
    Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
    Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
    Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
    Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.